Form 4: Credo CEO Sells Shares, Gifts to Charity

Sentiment:

Insider Transaction Report


Credo Technology Group Holding Ltd's CEO, William Joseph Brennan, reported multiple sales of ordinary shares and a gift of shares to a charitable trust, all executed on December 11, 2025.

Summary

  • William Joseph Brennan, President & Chief Executive Officer and Director of Credo Technology Group Holding Ltd (CRDO), reported several transactions involving ordinary shares on December 11, 2025.
  • Sales of 49,900 ordinary shares were executed indirectly through The Brennan Family Trust at weighted average prices ranging from $149.4012 to $159.1963 per share.
  • Sales of 18,016 ordinary shares were executed directly at weighted average prices ranging from $149.356 to $159.1964 per share.
  • All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025.
  • A gift of 10,000 ordinary shares was made from The Brennan Family Trust to The Brennan Family Fund, a charitable remainder trust, with a reported price of $0.
  • Following these transactions, Brennan's indirect beneficial ownership through The Brennan Family Trust decreased to 1,882,502 shares, and his direct beneficial ownership decreased to 301,891 shares.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, including sales under a pre-planned 10b5-1 program and a charitable gift, which are generally neutral events for company sentiment and do not indicate a change in fundamental outlook.

Positives

  • Sales were executed pursuant to a Rule 10b5-1 trading plan, indicating pre-scheduled transactions rather than a reaction to recent events or non-public information.
  • A gift of 10,000 ordinary shares was made to a charitable remainder trust, demonstrating philanthropic activity.

Negatives

  • William Joseph Brennan, a key executive and director, disposed of a significant number of ordinary shares (67,916 shares in total) through multiple sales.

Future Outlook

NA

Management Comments

  • Sales were executed pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025.
  • The reporting person disclaims beneficial ownership of shares held by The Brennan Family Trust except to the extent of his pecuniary interest therein.
  • The gift of 10,000 ordinary shares from The Brennan Family Trust was made to The Brennan Family Fund, a charitable remainder trust, with the Reporting Person not sharing any voting or investment power over these securities.

Industry Context

NA

Related Party Transactions

  • A gift of 10,000 ordinary shares was made from The Brennan Family Trust to The Brennan Family Fund, a charitable remainder trust.

Stakeholder Impact

  • Shareholders may observe a decrease in insider ownership, although the sales were pre-planned under a Rule 10b5-1 program, which typically mitigates concerns about opportunistic selling.

Key Dates

DateDescription
09/06/2002Date of The Brennan Family Trust establishment.
04/15/2025Rule 10b5-1 trading plan adopted by the reporting person.
12/11/2025Date of earliest transaction, including multiple sales and a gift of ordinary shares.
12/15/2025Signature date of the Form 4 filing.

Recommendation

hold

The filing details pre-scheduled insider sales under a Rule 10b5-1 plan and a charitable gift by the CEO. These are routine transactions and do not typically signal a change in the company's fundamental outlook or warrant a significant shift in investment strategy based solely on this report. Therefore, a 'hold' recommendation is appropriate.

Keywords

Credo Technology, CRDO, Insider Trading, Form 4, Share Sale, CEO, William Joseph Brennan, 10b5-1 Plan, Stock Transaction, Charitable Gift

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.